On the public citation graph
Repurposing of FDA ‐approved drugs against active site and potential allosteric drug‐binding sites of COVID ‐19 main protease
0 signed · 158 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2021.3071openalex-snapshot
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
inferredcites →https://doi.org/10.1002/cld.332openalex-snapshot
Recent FDA approval of sofosbuvir and simeprevir. Implications for current HCV treatment
inferredcites →https://doi.org/10.1002/cmdc.201500469openalex-snapshot
Designing Irreversible Inhibitors—Worth the Effort?
inferredcites →https://doi.org/10.1002/jcc.10128openalex-snapshot
Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation
inferredcites →https://doi.org/10.1002/jcc.20035openalex-snapshot
Development and testing of a general amber force field
inferredcites →https://doi.org/10.1002/jcc.21306openalex-snapshot
Drug efficiency indices for improvement of molecular docking scoring functions
inferredcites →https://doi.org/10.1002/jcc.21334openalex-snapshot
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
inferredcites →https://doi.org/10.1002/jcc.540100209openalex-snapshot
Optimization of parameters for semiempirical methods II. Applications
inferredcites →https://doi.org/10.1002/prot.26164openalex-snapshot
Repurposing of FDA ‐approved drugs against active site and potential allosteric drug‐binding sites of COVID ‐19 main protease
inferredcites →https://doi.org/10.1007/978-1-4419-5913-3_54openalex-snapshot
Docking to Large Allosteric Binding Sites on Protein Surfaces
inferredcites →https://doi.org/10.1007/s00894-020-04600-4openalex-snapshot
Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA
inferredcites →https://doi.org/10.1007/s10822-020-00356-4openalex-snapshot
Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein
inferredcites →https://doi.org/10.1007/s10930-020-09884-2openalex-snapshot
Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective
inferredcites →https://doi.org/10.1007/s13238-011-1034-1openalex-snapshot
Activation and maturation of SARS-CoV main protease
inferredcites →https://doi.org/10.1016/0021-9991(77)90098-5openalex-snapshot
Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes
inferredcites →https://doi.org/10.1016/j.antiviral.2016.04.014openalex-snapshot
Novel antiviral activity of bromocriptine against dengue virus replication
inferredcites →https://doi.org/10.1016/j.antiviral.2017.02.002openalex-snapshot
Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor
inferredcites →https://doi.org/10.1016/j.antiviral.2020.104787openalex-snapshot
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
inferredcites →https://doi.org/10.1016/j.bbagen.2017.09.005openalex-snapshot
Identification of potential allosteric communication pathways between functional sites of the bacterial ribosome by graph and elastic network models
inferredcites →https://doi.org/10.1016/j.chphi.2021.100011openalex-snapshot
Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
inferredcites →https://doi.org/10.1016/j.compbiomed.2021.104359openalex-snapshot
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
inferredcites →https://doi.org/10.1016/j.coph.2019.07.006openalex-snapshot
Improving therapy of severe infections through drug repurposing of synergistic combinations
inferredcites →https://doi.org/10.1016/j.ijantimicag.2020.106080openalex-snapshot
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
inferredcites →https://doi.org/10.1016/j.ijbiomac.2020.09.098openalex-snapshot
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach
inferredcites →https://doi.org/10.1016/j.jmgm.2020.107762openalex-snapshot
Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach
inferredcites →https://doi.org/10.1016/j.lfs.2020.117883openalex-snapshot
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
inferredcites →https://doi.org/10.1016/j.lfs.2020.118275openalex-snapshot
Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
inferredcites →https://doi.org/10.1016/j.mehy.2020.109766openalex-snapshot
Phytotherapeutics and SARS-CoV-2 infection: Potential role of bioflavonoids
inferredcites →https://doi.org/10.1016/j.mehy.2020.109957openalex-snapshot
Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?
inferredcites →https://doi.org/10.1016/j.polymer.2003.10.092openalex-snapshot
Unfolding events of Chymotrypsin Inhibitor 2 (CI2) revealed by Monte Carlo (MC) simulations and their consistency from structure-based analysis of conformations
inferredcites →https://doi.org/10.1016/j.sbi.2015.10.004openalex-snapshot
Allosteric sites: remote control in regulation of protein activity
inferredcites →https://doi.org/10.1016/j.str.2009.06.008openalex-snapshot
The Origin of Allosteric Functional Modulation: Multiple Pre-existing Pathways
inferredcites →https://doi.org/10.1021/acs.biochem.0c00160openalex-snapshot
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms
inferredcites →https://doi.org/10.1021/acs.jcim.0c00326openalex-snapshot
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure–Activity Relationship Studies
inferredcites →https://doi.org/10.1021/acs.jcim.0c00491openalex-snapshot
Computational Determination of Potential Inhibitors of SARS-CoV‑2 Main Protease
inferredcites →https://doi.org/10.1021/acs.jcim.0c00546openalex-snapshot
Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV‑2 Main Protease
inferredcites →https://doi.org/10.1021/acs.jcim.0c00634openalex-snapshot
Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV‑2 Mpro
inferredcites →https://doi.org/10.1021/acs.jcim.0c00967openalex-snapshot
Local and Global Motions Underlying Antibiotic Binding in Bacterial Ribosome
inferredcites →https://doi.org/10.1021/acs.jcim.0c01030openalex-snapshot
Interactive Molecular Dynamics in Virtual Reality Is an Effective Tool for Flexible Substrate and Inhibitor Docking to the SARS-CoV‑2 Main Protease
inferredcites →https://doi.org/10.1021/acs.jctc.5b00255openalex-snapshot
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01461openalex-snapshot
An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
inferredcites →https://doi.org/10.1021/acsptsci.0c00130openalex-snapshot
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV‑2 Main Protease Inhibitors
inferredcites →https://doi.org/10.1021/bi061746yopenalex-snapshot
SARS CoV Main Proteinase: The Monomer−Dimer Equilibrium Dissociation Constant
inferredcites →https://doi.org/10.1021/ci049714+openalex-snapshot
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
inferredcites →https://doi.org/10.1021/ci100275aopenalex-snapshot
Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations
inferredcites →https://doi.org/10.1021/ct100578zopenalex-snapshot
PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical p K a Predictions
inferredcites →https://doi.org/10.1021/ct300418hopenalex-snapshot
MMPBSA.py : An Efficient Program for End-State Free Energy Calculations
inferredcites →https://doi.org/10.1038/nrd.2015.37openalex-snapshot
Coronaviruses — drug discovery and therapeutic options
inferredcites →https://doi.org/10.1038/s41422-020-0356-zopenalex-snapshot
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
inferredcites →https://doi.org/10.1038/s41467-020-18096-2openalex-snapshot
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
inferredcites →https://doi.org/10.1038/s41467-020-18233-xopenalex-snapshot
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
inferredcites →https://doi.org/10.1038/s41467-020-18709-wopenalex-snapshot
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
inferredcites →https://doi.org/10.1038/s41586-020-2223-yopenalex-snapshot
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
inferredcites →https://doi.org/10.1038/s41598-020-59686-wopenalex-snapshot
Effect of nanoencapsulation on volatile constituents, and antioxidant and anticancer activities of Algerian Origanum glandulosum Desf. essential oil
inferredcites →https://doi.org/10.1038/s41598-020-71188-3openalex-snapshot
Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
inferredcites →https://doi.org/10.1038/s41598-020-74715-4openalex-snapshot
Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
inferredcites →https://doi.org/10.1038/s41598-022-21034-5openalex-snapshot
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
inferredcites →https://doi.org/10.1038/srep33213openalex-snapshot
Residue Geometry Networks: A Rigidity-Based Approach to the Amino Acid Network and Evolutionary Rate Analysis
inferredcites →https://doi.org/10.1039/d0ra08304fopenalex-snapshot
Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease
inferredcites →https://doi.org/10.1039/d0sc02823aopenalex-snapshot
Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 M pro by QM/MM computational methods
inferredcites →https://doi.org/10.1039/d0sc06195fopenalex-snapshot
Mechanism of inhibition of SARS-CoV-2 M pro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity
inferredcites →https://doi.org/10.1056/nejmoa2001017openalex-snapshot
A Novel Coronavirus from Patients with Pneumonia in China, 2019
inferredcites →https://doi.org/10.1056/nejmoa2007764openalex-snapshot
Remdesivir for the Treatment of Covid-19 — Final Report
inferredcites →https://doi.org/10.1056/nejmoa2021436openalex-snapshot
Dexamethasone in Hospitalized Patients with Covid-19
inferredcites →https://doi.org/10.1063/1.1667473openalex-snapshot
Synchronization of trajectories in canonical molecular-dynamics simulations: Observation, explanation, and exploitation
inferredcites →https://doi.org/10.1063/1.445869openalex-snapshot
Comparison of simple potential functions for simulating liquid water
inferredcites →https://doi.org/10.1063/1.464397openalex-snapshot
Particle mesh Ewald: An N ⋅log( N ) method for Ewald sums in large systems
inferredcites →https://doi.org/10.1073/pnas.2012201118openalex-snapshot
Bepridil is potent against SARS-CoV-2 in vitro
inferredcites →https://doi.org/10.1073/pnas.2024420118openalex-snapshot
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
inferredcites →https://doi.org/10.1080/07391102.2020.1779819openalex-snapshot
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
inferredcites →https://doi.org/10.1080/07391102.2020.1782768openalex-snapshot
Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL pro
inferredcites →https://doi.org/10.1080/07391102.2020.1802346openalex-snapshot
In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials
inferredcites →https://doi.org/10.1093/nar/gkj067openalex-snapshot
DrugBank: a comprehensive resource for in silico drug discovery and exploration
inferredcites →https://doi.org/10.1093/nar/gkq396openalex-snapshot
DNABINDPROT: fluctuation-based predictor of DNA-binding residues within a network of interacting residues
inferredcites →https://doi.org/10.1099/jmm.0.001203openalex-snapshot
Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2
inferredcites →https://doi.org/10.1103/physrevlett.79.3090openalex-snapshot
Gaussian Dynamics of Folded Proteins
inferredcites →https://doi.org/10.1111/bcpt.13537openalex-snapshot
The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitro
inferredcites →https://doi.org/10.1126/sciadv.abe0751openalex-snapshot
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L
inferredcites →https://doi.org/10.1126/science.abb3405openalex-snapshot
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
inferredcites →https://doi.org/10.1126/science.abf7945openalex-snapshot
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
inferredcites →https://doi.org/10.1128/aac.00754-20openalex-snapshot
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
inferredcites →https://doi.org/10.1128/aac.00819-20openalex-snapshot
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
inferredcites →https://doi.org/10.1128/aac.03036-14openalex-snapshot
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
inferredcites →https://doi.org/10.1128/cmr.00023-07openalex-snapshot
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection
inferredcites →https://doi.org/10.1128/cmr.00102-14openalex-snapshot
Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
inferredcites →https://doi.org/10.1146/annurev.biophys.093008.131258openalex-snapshot
Global Dynamics of Proteins: Bridging Between Structure and Function
inferredcites →https://doi.org/10.1186/1758-2946-3-33openalex-snapshot
Open Babel: An open chemical toolbox
inferredcites →https://doi.org/10.1186/s43141-020-00085-zopenalex-snapshot
A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods
inferredcites →https://doi.org/10.1208/s12248-007-9000-9openalex-snapshot
The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review
inferredcites →https://doi.org/10.1371/journal.pone.0074320openalex-snapshot
Hot Spots in a Network of Functional Sites
inferredcites →https://doi.org/10.1517/17460441.2012.688744openalex-snapshot
Drug discovery for a new generation of covalent drugs
inferredcites →https://doi.org/10.1529/biophysj.105.064485openalex-snapshot
A Network Representation of Protein Structures: Implications for Protein Stability
inferredcites →https://doi.org/10.20944/preprints202004.0334.v1openalex-snapshot
Molecular Docking and Molecular Dynamic Study of Two Viral Proteins Associated with SARS-CoV-2 with Ivermectin
inferredcites →https://doi.org/10.21203/rs.3.rs-72576/v1openalex-snapshot
Repurposing of FDA approved drugs targeting Main protease MPro for SARS-CoV-2
inferredcites →https://doi.org/10.2174/092986709788682065openalex-snapshot
Antiviral and Virucidal Activities of Natural Products
inferredcites →https://doi.org/10.2174/157340911795677602openalex-snapshot
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
inferredcites →https://doi.org/10.2174/1875038901003010123openalex-snapshot
A Spectrophotometric Method for Diosmin Determination
inferredcites →https://doi.org/10.2217/fvl-2020-0099openalex-snapshot
Possible SARS-coronavirus 2 Inhibitor Revealed By Simulated Molecular Docking to Viral Main Protease and Host toll-like Receptor
inferredcites →https://doi.org/10.23750/abm.v91i1.9397openalex-snapshot
WHO Declares COVID-19 a Pandemic.
inferredcites →https://doi.org/10.26434/chemrxiv.12115251.v1openalex-snapshot
Drug Repurposing of Approved Drugs Elbasvir, Ledipasvir, Paritaprevir, Velpatasvir, Antrafenine and Ergotamine for Combating COVID19
inferredcites →https://doi.org/10.3389/fphar.2018.01030openalex-snapshot
Repurposing of Bromocriptine for Cancer Therapy
inferredcites →https://doi.org/10.3389/fphar.2021.683296openalex-snapshot
Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial
inferredcites →https://doi.org/10.3390/ijms21155346openalex-snapshot
Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
inferredcites →https://doi.org/10.3906/biy-1802-77openalex-snapshot
Exploring allosteric communication in multiple states of the bacterial ribosome using residue network analysis
inferredcites →https://doi.org/10.4081/idr.2020.8543openalex-snapshot
National Institute for the Infectious Diseases “L. Spallanzani” IRCCS. Recommendations for COVID-19 Clinical Management
inferredcites →https://doi.org/10.4155/fmc-2020-0147openalex-snapshot
Tackling SARS-CoV-2: Proposed Targets and Repurposed Drugs
inferredcites →https://doi.org/10.48550/arxiv.2006.06523openalex-snapshot
Predicting inhibitors for SARS-CoV-2 RNA-dependent RNA polymerase using machine learning and virtual screening
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/cbdv.202501571openalex-snapshot
In Silico Screening of Flavonoids From Cycas as Potential Aromatase Inhibitors for Breast Cancer Therapy and Estimation of Total Flavonoid Content and LC–MS Analysis of Cycas revoluta Extract
inferred← citeshttps://doi.org/10.1002/cphc.202400814openalex-snapshot
Computational Assessment of Clinical Drugs against SARS‐CoV‐2: Foreseeing Molecular Mechanisms and Potent Mpro Inhibitors
inferred← citeshttps://doi.org/10.1002/mco2.254openalex-snapshot
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
inferred← citeshttps://doi.org/10.1002/prot.26318openalex-snapshot
Structural insights into the substrate‐binding site of main protease for the structure‐based COVID‐19 drug discovery
inferred← citeshttps://doi.org/10.1002/prot.26341openalex-snapshot
Integrated bioinformatics–cheminformatics approach toward locating pseudo‐potential antiviral marine alkaloids against SARS‐CoV‐2‐Mpro
inferred← citeshttps://doi.org/10.1002/prot.70122openalex-snapshot
Computationally Efficient Network Models Successfully Predict Allosteric Sites of SARS ‐ CoV ‐2 Main Protease and Reveal Its Dynamic Allostery
inferred← citeshttps://doi.org/10.1002/vjch.202200096openalex-snapshot
Investigation of ZINC85862539_679 to inhibit SARS‐CoV‐2 main protease: DFT calculation and molecular docking
inferred← citeshttps://doi.org/10.1007/s11224-022-01999-9openalex-snapshot
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics
inferred← citeshttps://doi.org/10.1007/s11224-022-02020-zopenalex-snapshot
Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
inferred← citeshttps://doi.org/10.1007/s13659-024-00486-4openalex-snapshot
Unveiling the mechanism of action of a novel natural dual inhibitor of SARS-CoV-2 Mpro and PLpro with molecular dynamics simulations
inferred← citeshttps://doi.org/10.1007/s40495-022-00285-wopenalex-snapshot
Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2022.107692openalex-snapshot
Interaction of the new inhibitor paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: A volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT
inferred← citeshttps://doi.org/10.1016/j.ejmcr.2021.100018openalex-snapshot
Prospective mode of action of Ivermectin: SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2022.09.204openalex-snapshot
Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.149258openalex-snapshot
A biophysical and computational investigation of aggregation suppression effect of choline dodecyl prolate ionic liquid on alpha lactalbumin protein
inferred← citeshttps://doi.org/10.1016/j.jmgm.2021.108050openalex-snapshot
Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition
inferred← citeshttps://doi.org/10.1016/j.jmgm.2024.108817openalex-snapshot
A computational workflow to determine drug candidates alternative to aminoglycosides targeting the decoding center of E. coli ribosome
inferred← citeshttps://doi.org/10.1016/j.molstruc.2024.137744openalex-snapshot
Use of hybrid molecular simulation techniques for systematic analysis of polyphenols as promising therapeutic agent against SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.rineng.2025.108719openalex-snapshot
Molecular dynamics insights into allosteric and orthosteric co-targeting of Mycobacterium tuberculosis thymidylate kinase: A structure-based approach for bitopic ligand design
inferred← citeshttps://doi.org/10.1021/acs.jcim.1c01223openalex-snapshot
Computational Identification of Possible Allosteric Sites and Modulators of the SARS-CoV-2 Main Protease
inferred← citeshttps://doi.org/10.1021/acs.jcim.6c00004openalex-snapshot
RinPy, a Python Package for Residue Interaction Network Model to Analyze Protein Structures and Predict Ligand Binding Sites
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c01043openalex-snapshot
Toward the Design of Allosteric Effectors: Gaining Comprehensive Control of Drug Properties and Actions
inferred← citeshttps://doi.org/10.1021/acs.jpcb.4c00925openalex-snapshot
Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation
inferred← citeshttps://doi.org/10.1021/acsomega.4c06172openalex-snapshot
Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive Saturation
inferred← citeshttps://doi.org/10.1080/07391102.2022.2051743openalex-snapshot
Exploring species-specific inhibitors with multiple target sites on S. aureus pyruvate kinase using a computational workflow
inferred← citeshttps://doi.org/10.1080/07391102.2022.2107573openalex-snapshot
Molecular dynamics and docking studies on potentially active natural phytochemicals for targeting SARS-CoV-2 main protease
inferred← citeshttps://doi.org/10.1080/17415993.2022.2119086openalex-snapshot
Virtual screening of sulfur compounds of Allium against coronavirus proteases: E-Ajoene is a potential dual protease targeting covalent inhibitor
inferred← citeshttps://doi.org/10.1111/1440-1681.13678openalex-snapshot
Bromocriptine therapy: Review of mechanism of action, safety and tolerability
inferred← citeshttps://doi.org/10.1186/s12859-026-06590-1openalex-snapshot
BENDER DB: a database of protein binding sites across neglected disease proteomes
inferred← citeshttps://doi.org/10.1371/journal.pntd.0013963openalex-snapshot
Molecular docking approaches in mycetoma: Toward improved patient management
inferred← citeshttps://doi.org/10.17576/jsm-2024-5305-01openalex-snapshot
Unlocking Therapeutic Potential: Identifying Small Molecule Inhibitors for Sars-Cov-2 Variants' Main Protease (MPRO) Through Molecular Docking Analysis
inferred← citeshttps://doi.org/10.19113/sdufenbed.1121167openalex-snapshot
Pharmacophore Modeling Guided by Conformational Dynamics Reveals Potent Anticancer Agents
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1465489/v1openalex-snapshot
Molecular dynamics and docking studies on potentially active natural phytochemicals for targeting SARS-CoV-2 Main Protease
inferred← citeshttps://doi.org/10.2142/biophysico.bppb-v18.025openalex-snapshot
Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins
inferred← citeshttps://doi.org/10.2147/dddt.s370574openalex-snapshot
Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
inferred← citeshttps://doi.org/10.2174/0109298673296749240207115303openalex-snapshot
Structural-based Study to Identify the Repurposed Candidates against Bacterial Infections
inferred← citeshttps://doi.org/10.2174/1386207325666220816125639openalex-snapshot
Evaluations of FDA-approved Drugs Targeting 3CLP of SARS-CoV-2 Employing a Repurposing Strategy
inferred← citeshttps://doi.org/10.2174/1386207325666220818141112openalex-snapshot
In silico Identification of Novel SARS-CoV-2 Main Protease and Nonstructural Protein 13 (nsp13) Inhibitors through Consensus Docking and Free Binding Energy Calculations
inferred← citeshttps://doi.org/10.33435/tcandtc.1121985openalex-snapshot
An in silico investigation of allosteric inhibition potential of Dihydroergotamine against Sars-CoV-2 Main Protease (MPro)
inferred← citeshttps://doi.org/10.3389/fmolb.2024.1451280openalex-snapshot
A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis
inferred← citeshttps://doi.org/10.3390/antibiotics10081011openalex-snapshot
Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
inferred← citeshttps://doi.org/10.3390/catal13030605openalex-snapshot
Exploring the Potential of Black Soldier Fly Larval Proteins as Bioactive Peptide Sources through in Silico Gastrointestinal Proteolysis: A Cheminformatic Investigation
inferred← citeshttps://doi.org/10.3390/ijms26073293openalex-snapshot
In Silico Identification of Putative Allosteric Pockets and Inhibitors for the KRASG13D-SOS1 Complex in Cancer Therapy
inferred← citeshttps://doi.org/10.3390/life12091384openalex-snapshot
Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic
inferred← citeshttps://doi.org/10.3390/molecules27134210openalex-snapshot
In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19
inferred← citeshttps://doi.org/10.3390/molecules27248773openalex-snapshot
Virtual Screening of FDA-Approved Drugs for Enhanced Binding with Mitochondrial Aldehyde Dehydrogenase
inferred← citeshttps://doi.org/10.3390/molecules28186696openalex-snapshot
Antiviral Effect of 5′-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.3390/v14071458openalex-snapshot
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
showing the first 49 of 50 · page through all 50
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.